Testing Doublebase Once Moisturizer for Atopic Eczema
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study tests a moisturizer called Doublebase Once for people with atopic eczema. You apply it once a day for 4 weeks to see how well it improves skin moisture and eczema symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have atopic eczema (personal or family history of eczema, asthma, or hay fever)
- Your eczema severity score (SCORAD) must be at least 15 at the start of the study
- You normally use a leave-on moisturizer regularly to manage your eczema
- You cannot be currently using antibiotics (by mouth or on the skin) or Doublebase Once
- You must be willing to use Doublebase Once as your only leave-on moisturizer once daily for 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a moisturizer called Doublebase Once in people with ichthyosis (a condition causing dry, scaly skin). For one month, you'd use this product once daily instead of your usual moisturizer to see if it works well and is safe.
This study tests whether a moisturiser called Doublebase Once is safe and works well for people with psoriasis. You would use this moisturiser instead of your usual one for about a month to see how your skin reacts and feels.
This study tests a new moisturizing product (RV4421B) for people with mild to moderate atopic dermatitis (eczema). Participants will use the product along with their usual steroid cream for 12 weeks to see how well it works and if it’s safe for different ages, from babies to adults.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
This study tests an oral medication (EC-18) for moderate to severe atopic dermatitis (eczema) to see if it can improve symptoms like itching and skin rash. It may be an option for people whose eczema is not controlled by topical treatments.
This trial tests if two different moisturizing balms work equally well for treating mild to moderate eczema (atopic dermatitis) in children and adults. It may help find a more affordable or better-tolerated option.
Hear when a new Atopic Eczema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.